Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Taking a bite out of Charcot-Marie-Tooth Disease

    ... types of CMT that don’t involve PMP22 at all. Schwann cells, the “bodyguards” of nerve cells, wrap around nerve fibers, providing ... manager of corporate alliances for Vanderbilt’s Center for Technology Transfer and Commercialization,  attended a global conference ...

    sommers - 03/18/2024 - 1:36pm

  2. Use of Fluid Shear Stress Treatment to Enhance T Cell Activation

    ... a technique to enhance immune cell activation by exposing cells to mechanical force while culturing. Proof-of-concept data indicate that ... effective in activating all types of T cells.   Technology Description Vanderbilt scientists have pioneered a method ...

    cttc_admin - 01/18/2024 - 9:10am

  3. ThermoFisher Scientific - Research Interest Areas

    ... analysis of recombinant protein quality; rapid bioburden technology; bioprocess data analytics; technologies for new biotherapeutic ... culture and cryo-preservation media for immune and stem cells; novel characterization assays and analytics Food safety and ...

    cttc_admin - 01/30/2024 - 12:26pm

  4. Rethinking drug efficacy: research aims to improve drug development

    ... in ways that more closely mimic how they will behave in the human body, potentially reducing the failure rate of drugs in clinical ... Postdoctoral Fellow in 2023, are developing a startup with technology that will allow drug developers to test the impact of ... altering the current drug development procedures, the technology has potential to facilitate the creation of entirely novel drug ...

    sommers - 03/11/2024 - 8:54am

  5. Innovation Catalyst Fund announces eight inaugural awardees; next round submission deadline is April 15

    ... Cybele Raver and Vice Chancellor for Finance and Information Technology Brett Sweet, received 24 submissions and will provide pre-seed ... are: Amy Booth , professor of psychology and human development: “Advancing the Development of AIDA, an ... to be refined for potential resubmission. The Center for Technology Transfer and Commercialization manages the proposal submission and ...

    sommers - 02/13/2024 - 10:43am

  6. Wikswo and VIIBRE team on track to build third-generation ‘self-driving lab’ with $1M from National Science Foundation

    ... biotechnologies, and the Chinese hamster ovary (CHO) cells used to produce antibody-based drugs and vaccines.  Wikswo had ... professor of machine intelligence at Chalmers University of Technology in Gothenberg, Sweden, and the developer of Adam and Eve, the first ...

    sommers - 05/04/2022 - 10:19am

  7. Vanderbilt investigators lead effort to create map of the human kidney

    ... Caprioli, who pioneered a remarkable tissue-mapping technology called imaging mass spectrometry and who directs Vanderbilt’s Mass ... the late 1990s to visualize the location of biomolecules in cells and tissues. Essentially a “molecular microscope,” it measures the ...

    sommers - 11/05/2019 - 8:39am

  8. Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial

    ... as a treatment for neuropsychiatric disorders.”  Human clinical trials are a significant advancement in a five-step  drug ... collaboration was facilitated by the   Center for Technology Transfer and Commercialization . Vanderbilt researchers who ...

    sommers - 01/17/2024 - 10:08am

  9. Theralink® Acquires Exclusive Landmark Immunotherapy Patent including Biomarker from Vanderbilt University

    ... 16 other important protein markers found expressed in tumor cells and surrounding immune cells wherein immunotherapy treatments can be ... and protein biomarker platform and LDTs, Theralink’s technology targets multiple areas of oncology and drug development. In addition ...

    sommers - 04/24/2023 - 1:45pm

  10. The yin and yang of cell signaling

    ... Lawrence Marnett , PhD, and colleagues used CRISPR-Cas9 technology to generate stable knock-outs of LYPLA1 and/or LYPLA2 in mouse ... each other and cooperatively maintained LysoPL levels in the cells. However, deletion of both enzymes led to dramatically increased ...

    sommers - 02/21/2019 - 9:51am